C Wheeler

896 total citations
23 papers, 686 citations indexed

About

C Wheeler is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, C Wheeler has authored 23 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in C Wheeler's work include Hematopoietic Stem Cell Transplantation (8 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Cells and Metastasis (4 papers). C Wheeler is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Cells and Metastasis (4 papers). C Wheeler collaborates with scholars based in United States and Germany. C Wheeler's co-authors include E Frei, Anthony Elias, Lois Ayash, Paul G. Richardson, Lowell E. Schnipper, Karen H. Antman, Lynne Uhl, W M Hryniuk, Gary N. Schwartz and JH Antin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

C Wheeler

23 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C Wheeler United States	12	343	209	203	105	102	23	686
Paul M. Sondel United States	17	421 1.2×	184 0.9×	237 1.2×	57 0.5×	47 0.5×	41	1.1k
M. Brandely France	14	262 0.8×	119 0.6×	164 0.8×	138 1.3×	44 0.4×	36	760
Amu Therwath France	16	210 0.6×	257 1.2×	63 0.3×	46 0.4×	111 1.1×	39	745
Mariko Ishibashi Japan	13	322 0.9×	297 1.4×	309 1.5×	42 0.4×	58 0.6×	36	748
Jochen Casper Germany	13	145 0.4×	241 1.2×	313 1.5×	86 0.8×	17 0.2×	39	701
A. Krämer Germany	14	251 0.7×	323 1.5×	229 1.1×	40 0.4×	68 0.7×	31	723
Mikinori Miyazaki Japan	13	375 1.1×	303 1.4×	111 0.5×	202 1.9×	81 0.8×	32	889
Nora Ku United States	11	168 0.5×	128 0.6×	250 1.2×	124 1.2×	57 0.6×	24	584
Michael J. Allegrezza United States	15	737 2.1×	641 3.1×	67 0.3×	109 1.0×	124 1.2×	18	1.4k
I. H. Krakoff United States	8	203 0.6×	445 2.1×	57 0.3×	85 0.8×	80 0.8×	14	755

Countries citing papers authored by C Wheeler

Since Specialization

Citations

This map shows the geographic impact of C Wheeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Wheeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Wheeler more than expected).

Fields of papers citing papers by C Wheeler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Wheeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Wheeler. The network helps show where C Wheeler may publish in the future.

Co-authorship network of co-authors of C Wheeler

This figure shows the co-authorship network connecting the top 25 collaborators of C Wheeler. A scholar is included among the top collaborators of C Wheeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Wheeler. C Wheeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Chiuzan, Codruța, Amy Tiersten, CL Shapiro, et al.. (2017). Abstract OT1-01-10: Multi-center phase IB trial of ACY-1215 (Ricolinostat) combined with nab-paclitaxel in unresectable or metastatic breast cancer. Cancer Research. 77(4_Supplement). OT1–1. 1 indexed citations

2.

Baselga, José, Federico Rojo, Andy Ryan, et al.. (2005). Pharmacodynamic assessment of ZD6474 (ZACTIMA (TM)) in the skin of patients with previously treated metastatic breast cancer.. Clinical Cancer Research. 11. 1 indexed citations

3.

Medinger, Michael, K. Mross, Ute Zirrgiebel, et al.. (2004). Phase I dose-escalation study of the highly potent VEGF receptor kinase inhibitor, AZD2171, in patients with advanced cancers with liver metastases. Journal of Clinical Oncology. 22(14_suppl). 3055–3055. 10 indexed citations

4.

Medinger, Michael, K. Mross, Ute Zirrgiebel, et al.. (2004). Phase I dose-escalation study of the highly potent VEGF receptor kinase inhibitor, AZD2171, in patients with advanced cancers with liver metastases. Journal of Clinical Oncology. 22(14_suppl). 3055–3055. 12 indexed citations

5.

Stiff, Pat, R. Gingrich, Selina M. Luger, et al.. (2000). A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma. Bone Marrow Transplantation. 26(5). 471–481. 72 indexed citations

6.

Frei, Emil, Paul G. Richardson, David Avigan, et al.. (1999). The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses. Bone Marrow Transplantation. 24(9). 939–945. 8 indexed citations

7.

Frei, E, Anthony Elias, C Wheeler, Paul G. Richardson, & W M Hryniuk. (1998). The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity.. PubMed. 4(9). 2027–37. 78 indexed citations

8.

Sieff, Colin A., et al.. (1997). Preapheresis peripheral blood CD34+ mononuclear cell counts as predictors of progenitor cell yield. Transfusion. 37(1). 79–85. 46 indexed citations

9.

Gorlin, Jed B., et al.. (1997). Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components. Transfusion. 37(6). 585–591. 124 indexed citations

10.

Webb, Iain J., AD Elias, Lois Ayash, et al.. (1996). Kinetics of peripheral blood mononuclear cell mobilization with chemotherapy and/or granulocyte‐colony‐stimulating factor: implications for yield of hematopoietic progenitor cell collections. Transfusion. 36(2). 160–167. 18 indexed citations

11.

Ayash, Lois, Anthony Elias, Gary N. Schwartz, et al.. (1996). Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.. Journal of Clinical Oncology. 14(11). 2984–2992. 43 indexed citations

12.

Ayash, Lois, C Wheeler, Diane L. Fairclough, et al.. (1995). Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.. Journal of Clinical Oncology. 13(8). 2043–2049. 99 indexed citations

13.

Elias, Anthony, C Wheeler, I Tepler, et al.. (1994). High-dose ifosfamide/carboplatin/etoposide with autologous hematopoietic stem cell support: safety and future directions.. PubMed. 21(5 Suppl 12). 83–5. 4 indexed citations

14.

Elias, Anthony, Lois Ayash, I Tepler, et al.. (1993). The Use of G-CSF or GM-CSF Mobilized Peripheral Blood Progenitor Cells (PBPC) Alone or to Augment Marrow as Hematologic Support of Single or Multiple Cycle High-Dose Chemotherapy. Journal of Hematotherapy. 2(3). 377–382. 8 indexed citations

15.

Elias, Anthony, Lois Ayash, Arthur T. Skarin, et al.. (1993). High-Dose Combined Alkylating Agent Therapy With Autologous Stem Cell Support and Chest Radiotherapy for Limited Small-Cell Lung Cancer. CHEST Journal. 103(4). 433S–435S. 8 indexed citations

16.

Elias, Anthony, Lois Ayash, Emil Frei, et al.. (1993). Intensive Combined Modality Therapy for Limited-Stage Small-Cell Lung Cancer. JNCI Journal of the National Cancer Institute. 85(7). 559–566. 44 indexed citations

17.

Elias, Anthony, Rosemary Mazanet, Kenneth C. Anderson, et al.. (1992). GM-CSF mobilized peripheral blood stem cell autografts: The DFCI/BIH experience. Stem Cells. 10(S1). 149–151. 5 indexed citations

18.

Elias, AD, Lois Ayash, KC Anderson, et al.. (1992). Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood. 79(11). 3036–3044. 9 indexed citations

19.

Elias, Anthony, Lois Ayash, J. P. Eder, et al.. (1991). Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study. Journal of Cancer Research and Clinical Oncology. 117(S4). S208–S213. 6 indexed citations

20.

Elias, Anthony, Rosemary Mazanet, C Wheeler, et al.. (1991). GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: Two protocols. Breast Cancer Research and Treatment. 20(S1). S25–S29. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact